Market Research Logo

Exosome Diagnostics Inc - Product Pipeline Analysis, 2018 Update

Summary

Exosome Diagnostics Inc (Exosome Diagnostics) is a provider of diagnostic solutions. The company develops, designs, manufactures and markets biofluid-based molecular diagnostic tests and products for use in personalized medicine. Exosome Diagnostics’ services comprise miRNA profiling, mRNA profiling, mutation detection, ribonucleic acid (RNA) sequencing (including full RNA seq) and custom assay development services. The company also offers disease detection, diagnosis, treatment and monitoring. Its technology is used in the treatment of brain cancer, prostate cancer, and Alzheimer's disease. Exosome Diagnostics is headquartered in Waltham, Massachusetts the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Exosome Diagnostics Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Exosome Diagnostics Inc Company Overview
Exosome Diagnostics Inc Company Snapshot 5
Exosome Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
Exosome Diagnostics Inc – Pipeline Analysis Overview 7
Exosome Diagnostics Inc - Key Facts 7
Exosome Diagnostics Inc - Major Products and Services 8
Exosome Diagnostics Inc Pipeline Products by Development Stage 9
Exosome Diagnostics Inc Ongoing Clinical Trials by Trial Status 11
Exosome Diagnostics Inc Pipeline Products Overview 13
Biofluid Nucleic Acid Kit - Alzheimer's Disease 13
Biofluid Nucleic Acid Kit - Alzheimer's Disease Product Overview 13
Biofluid Nucleic Acid Kit - Cardiovascular Disease 14
Biofluid Nucleic Acid Kit - Cardiovascular Disease Product Overview 14
Biofluid Nucleic Acid Kit - Chronic Kidney Disease 15
Biofluid Nucleic Acid Kit - Chronic Kidney Disease Product Overview 15
Biofluid Nucleic Acid Kit - Parkinson's Disease 16
Biofluid Nucleic Acid Kit - Parkinson's Disease Product Overview 16
Biofluid-Based Molecular Diagnostic Test - Brain Cancer 17
Biofluid-Based Molecular Diagnostic Test - Brain Cancer Product Overview 17
BIONIC Liquid Biopsy - Bladder Cancer 18
BIONIC Liquid Biopsy - Bladder Cancer Product Overview 18
Diagnostic Test - Neurodegenerative Diseases 19
Diagnostic Test - Neurodegenerative Diseases Product Overview 19
EXO1000 20
EXO1000 Product Overview 20
ExoDx Lung(EGFR) 21
ExoDx Lung(EGFR) Product Overview 21
ExoDx Lung(EGFR) Clinical Trial 22
ExoDx Lung(T790M) 23
ExoDx Lung(T790M) Product Overview 23
ExoDx Prostate(IntelliScore) - IVD Version 24
ExoDx Prostate(IntelliScore) - IVD Version Product Overview 24
ExoDx Prostate(IntelliScore) - IVD Version Clinical Trial 25
Next-Generation Solid Tumor Mutation Panel 26
Next-Generation Solid Tumor Mutation Panel Product Overview 26
Shahky 27
Shahky Product Overview 27
Exosome Diagnostics Inc - Key Competitors 28
Exosome Diagnostics Inc - Key Employees 29
Exosome Diagnostics Inc - Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Exosome Diagnostics Inc, Recent Developments 31
Jun 13, 2018: Exosome Diagnostics Receives ISO 13485:2016 Certification 31
May 22, 2018: Exosome Diagnostics Announces Bladder Cancer Surveillance Panel 31
May 17, 2018: Exosome Diagnostics’ Second Prospective Validation Study of EPI to be Highlighted at American Urological Association (AUA) Annual Meeting Press Briefing in San Francisco, CA 32
May 15, 2018: Exosome Diagnostics Presents Breakthrough Data Highlighting Tumor Derived RNA in Biofluids at the International Society for Extracellular Vesicles in Spain 33
May 09, 2018: Exosome Diagnostics Continues to Expand Coverage Reach for its EPI Test 33
May 08, 2018: Exosome Diagnostics Expands National Sales Team after Blockbuster Quarter with its Flagship Diagnostic, ExoDx Prostate(IntelliScore) (EPI) Test 34
Apr 17, 2018: Exosome Diagnostics Obviates Tissue Biopsies 34
Mar 21, 2018: Exosome Diagnostics Names Grannum Sant As Head Of Medical Affairs 35
Feb 23, 2018: Exosome Diagnostics Expands its Coverage Reach for EPI to an Additional 82 Million Covered Lives in the United States 36
Feb 23, 2018: NIH Launches International Study of AMD Progression 36
Appendix 38
Methodology 38
About GlobalData 41
Contact Us 41
Disclaimer 41
List of Tables
Exosome Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview 5
Exosome Diagnostics Inc Pipeline Products by Equipment Type 6
Exosome Diagnostics Inc Pipeline Products by Indication 6
Exosome Diagnostics Inc Ongoing Clinical Trials by Trial Status 6
Exosome Diagnostics Inc, Key Facts 7
Exosome Diagnostics Inc, Major Products and Services 8
Exosome Diagnostics Inc Number of Pipeline Products by Development Stage 9
Exosome Diagnostics Inc Pipeline Products Summary by Development Stage 10
Exosome Diagnostics Inc Ongoing Clinical Trials by Trial Status 11
Exosome Diagnostics Inc Ongoing Clinical Trials Summary 12
Biofluid Nucleic Acid Kit - Alzheimer's Disease - Product Status 13
Biofluid Nucleic Acid Kit - Alzheimer's Disease - Product Description 13
Biofluid Nucleic Acid Kit - Cardiovascular Disease - Product Status 14
Biofluid Nucleic Acid Kit - Cardiovascular Disease - Product Description 14
Biofluid Nucleic Acid Kit - Chronic Kidney Disease - Product Status 15
Biofluid Nucleic Acid Kit - Chronic Kidney Disease - Product Description 15
Biofluid Nucleic Acid Kit - Parkinson's Disease - Product Status 16
Biofluid Nucleic Acid Kit - Parkinson's Disease - Product Description 16
Biofluid-Based Molecular Diagnostic Test - Brain Cancer - Product Status 17
Biofluid-Based Molecular Diagnostic Test - Brain Cancer - Product Description 17
BIONIC Liquid Biopsy - Bladder Cancer - Product Status 18
BIONIC Liquid Biopsy - Bladder Cancer - Product Description 18
Diagnostic Test - Neurodegenerative Diseases - Product Status 19
Diagnostic Test - Neurodegenerative Diseases - Product Description 19
EXO1000 - Product Status 20
EXO1000 - Product Description 20
ExoDx Lung(EGFR) - Product Status 21
ExoDx Lung(EGFR) - Product Description 21
ExoDx Lung(EGFR) - A Phase I/II, Open-label, Safety, Pharmacokinetic and Preliminary Efficacy Study of Oral Rociletinib in Patients with Previously Treated Mutant EGFR Non-small Cell Lung Cancer (NSCLC) 22
ExoDx Lung(T790M) - Product Status 23
ExoDx Lung(T790M) - Product Description 23
ExoDx Prostate(IntelliScore) - IVD Version - Product Status 24
ExoDx Prostate(IntelliScore) - IVD Version - Product Description 24
ExoDx Prostate(IntelliScore) - IVD Version - Clinical Evaluation of the 'ExoDx Prostate IntelliScore' in Men Presenting for Initial Biopsy; Additional Confirmation Study including Impact on Decision-making and Health Economics 25
Next-Generation Solid Tumor Mutation Panel - Product Status 26
Next-Generation Solid Tumor Mutation Panel - Product Description 26
Shahky - Product Status 27
Shahky - Product Description 27
Exosome Diagnostics Inc, Key Employees 29
Exosome Diagnostics Inc, Subsidiaries 30
Glossary 40
List of Figures
Exosome Diagnostics Inc Pipeline Products by Equipment Type 6
Exosome Diagnostics Inc Pipeline Products by Development Stage 9
Exosome Diagnostics Inc Ongoing Clinical Trials by Trial Status 11

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report